Luís Lima 1,2,3,4 and Daniela Oliveira 1; Ana Tavares 1,5; Teresina Amaro 6; Ricardo Cruz 7; Maria J. Oliveira 8,9,10; José A. Ferreira 1,11 and Lúcio Santos 1,12,13.
1 Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Porto, Portugal
2 ICBAS, Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal
